Final Days to Register: Pharmacovigilance for Drug Safety, Regulatory Affairs and PV Auditors Training Course (ONLINE EVENT: January 29-31, 2025 & ON-DEMAND)
15. Oktober 2024 10:40 ET
|
Research and Markets
Dublin, Oct. 15, 2024 (GLOBE NEWSWIRE) -- The "Pharmacovigilance for Drug Safety, Regulatory Affairs and PV Auditors - Broadening your Knowledge Training Course" conference has been added to ...
CRISPR Cas9 Market and Clinical Trials Report to 2029: CRISPR-Cas9 Therapy Clinical Trials By Company, County, Indication & Phase
12. August 2024 04:52 ET
|
Research and Markets
Dublin, Aug. 12, 2024 (GLOBE NEWSWIRE) -- The "CRISPR Cas9 Market Opportunity & Clinical Trials Outlook 2029" report has been added to ResearchAndMarkets.com's offering. The global landscape...
Emerging ONC201 Drug Set to Transform Glioblastoma Multiforme Treatment Landscape: Drug Insights and Market Forecasts to 2032
29. Januar 2024 12:18 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "ONC201 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This comprehensive report...
Otenaproxesul for Osteoarthritis: A Novel NSAID that Releases Hydrogen Sulfide - Emerging Drug Insight and Market Forecasts, 2019-2023 and 2023-2032
24. Januar 2024 09:14 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Otenaproxesul Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
ITI-1000 (pp65 DC vaccine) for Glioblastoma Multiforme (GBM): Emerging Drug Insights and Market Forecasts, 2019-2023 and 2023-2032 - Focus on US, Germany, France, Italy, Spain, UK, and Japan
24. Januar 2024 09:09 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "ITI-1000 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
RTX-GRT7039 (Resiniferatoxin) Emerging Drug Insights and Market Forecasts, 2019-2023 and 2023-2032: An Investigational Medicine for the Intra-Articular Treatment of Pain Associated with Knee OA
24. Januar 2024 08:01 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "RTX-GRT7039 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
3 Day Online Course: Pharmacovigilance for Drug Safety, Regulatory Affairs and PV Auditors - Broadening your Knowledge Training Course (January 31, 2024 February 2, 2024)
02. Oktober 2023 07:13 ET
|
Research and Markets
Dublin, Oct. 02, 2023 (GLOBE NEWSWIRE) -- The "Pharmacovigilance for Drug Safety, Regulatory Affairs and PV Auditors - Broadening your Knowledge Training Course" conference has been added to ...
Tiziana Life Sciences Initiates Multi-Center Phase 2a Clinical Trial of Intranasal Foralumab for Non-Active Secondary Progressive Multiple Sclerosis
26. September 2023 07:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
BIMZELX (bimekizumab): The 1st Humanized Monoclonal IgG1 Antibody that Potently and Selectively Neutralizes Both IL-17A and IL-17F - Emerging Drug Insights and Market Forecasts 2019-2023 & 2032
31. März 2023 07:33 ET
|
Research and Markets
Dublin, March 31, 2023 (GLOBE NEWSWIRE) -- The "Bimekizumab Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering."Bimekizumab Emerging Drug...
Two Weeks Until Pharmacovigilance for Drug Safety, Regulatory Affairs and PV Auditors - Broadening your Knowledge Training Course (February 22-24, 2023)
06. Februar 2023 05:48 ET
|
Research and Markets
Dublin, Feb. 06, 2023 (GLOBE NEWSWIRE) -- The "Pharmacovigilance for Drug Safety, Regulatory Affairs and PV Auditors - Broadening your Knowledge Training Course" conference has been added to ...